• 2014

Company Description

The First Viable Closed Loop Insulin Delivery System In The World.

DreaMed Diabetes was established in 2014 to commercialize the company’s industry-leading closed-loop solution for patients with Type 1&2 diabetes. DreaMed Diabetes is comprised of thought -leading endocrinologists and engineers who are devoted to developing new solutions for diabetes treatment and management. They understand clinical practice and strive to close the gap between patients and their optimal glycemic control.